NSF & Gadolinium Law
Patients with severe kidney insufficiency who receive gadolinium-based agents are at risk for developing a debilitating, and a potentially fatal disease known as nephrogenic systemic fibrosis (NSF).
If you have kidney problems and a recent MRI, please read more about our symptoms and resources on NSF.
If you have been diagnosed with nephrogenic systemic fibrosis (NSF) or believe you have nephrogenic systemic fibrosis (NSF) please fill out the inquiry form on our contact page.
Learn More about:
